Frédéric Vigneault

This paper identifies vorinostat as a potential repurposed therapy for Rett syndrome by combining computational network analysis with CRISPR-edited Xenopus models, showing efficacy across multiple organ systems.

The paper demonstrates a single-molecule method to screen polymerase variants using nanopore sequencing and barcoding, enabling multiplexed analysis of kinetic properties.